.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Brain health startup Ivory has introduced an innovative \"treadmill test\" for the brain to revolutionize cognitive health screening in India. This AI-powered platform makes brain functions like memory and attention measurable and trackable. Founded in 2023, the startup addresses a major gap in routine healthcare. While physical checkups track liver and heart health, cognition often remains unmonitored. Consequently, many patients only seek help when symptoms become severe.
Research indicates that approximately 35 million people in India may live with mild cognitive impairment. However, nearly 90% of these cases remain undiagnosed due to a lack of accessible tools. Early cognitive health screening can potentially delay the onset of serious conditions like dementia. Specifically, the platform targets individuals in their 40s to establish early baselines. By shifting from subjective questionnaires to objective data, Ivory helps clinicians provide better care. Furthermore, early intervention significantly improves long-term outcomes for aging populations.
The platform utilizes a mix of digital markers and voice-based biomarkers to assess neurological health. It measures attention, executive function, and memory through neuroscience-backed tasks. Users receive a baseline score benchmarked against their specific age and gender. Importantly, the tool helps doctors distinguish between permanent decline and lifestyle-driven issues like stress. Ongoing clinical trials in hospital settings continue to establish robust baseline datasets. Similarly, the startup is building intellectual property around these advanced screening capabilities.
Ivory recently raised $1 million to strengthen its product stack and expand clinical reach. The company has partnered with Metropolis Healthcare to integrate assessments into preventive health packages. Moreover, it is collaborating with performance platforms like Ultrahuman to reach health-conscious consumers. The broader goal involves embedding cognitive testing across insurance and corporate wellness programs. This multi-touchpoint approach ensures that brain health becomes a standard pillar of modern healthcare.
Q1: What is the brain \"treadmill test\"?
It is an AI-powered screening platform that objectively measures memory, attention, and executive function to track cognitive health.
Q2: At what age should one start cognitive screening?
Experts suggest starting as early as the 40s to establish a baseline and detect early signs of decline.
Q3: Can the test distinguish between stress and dementia?
Yes, the tool uses data-driven biomarkers to help clinicians differentiate between lifestyle issues like brain fog and early cognitive decline.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Brain health startup Ivory launches an AI-powered 'treadmill test' for the brain, aiming to integrate cognitive screening into routine preventive care in In...
4 months ago
A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today
Explore real-world data showing how private oncogenetics and molecular tumor boards achieve 3-week consult turnaround, high ctDNA actionability, and vital germline variant detection, enhancing individualized cancer care and familial risk assessment.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
